Mizuho initiated coverage of Exact Sciences (EXAS) with an Outperform rating and $60 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Strategic Developments and Product Launch Drive Buy Rating for Exact Sciences
- Exact Sciences announces launch of Cologuard Plus test
- Exact Sciences Positioned for Growth with Upcoming Product Launches and Margin Expansion
- Exact Sciences price target lowered to $60 from $73 at Guggenheim
- Exact Sciences: Strong Buy Rating Backed by Strategic Growth Initiatives and Favorable Market Positioning